HIV vaccine - Amgen/NIAID
Alternative Names: AIDS vaccine - Amgen/NIAID; Prophylactic HIV vaccine - Amgen/NIAIDLatest Information Update: 02 Oct 2021
At a glance
- Originator BioVex; National Institute of Allergy and Infectious Diseases
- Class AIDS vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 27 Apr 2006 No development reported - Preclinical for HIV infections prevention in United Kingdom (unspecified route)
- 27 Apr 2006 No development reported - Preclinical for HIV infections prevention in USA (unspecified route)
- 16 May 2003 Preclinical trials in HIV infections prevention in United Kingdom (unspecified route)